Artwork

Contenuto fornito da CEimpact. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da CEimpact o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !

Paxlovid in COVID-19 Vaccinated patients

26:21
 
Condividi
 

Manage episode 418005992 series 2931422
Contenuto fornito da CEimpact. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da CEimpact o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Join us as we explore new trial data examing Paxlovid's effectiveness in high-risk, vaccinated patients.
The GameChanger
Significantly high risk patients are still at risk from active Covid-19 infection. A new trial looks at Paxlovid use in high-risk, vaccincated patients.
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
New England Journal of Medicine Article
Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss EPIC SR study findings.
2. Describe benefits of Paxlovid for specific patient groups based on trial data.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-172-H01-P
Initial release date: 05/13/2024
Expiration date: 05/13/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

  continue reading

Capitoli

1. Paxlovid in COVID-19 Vaccinated patients (00:00:00)

2. COVID Treatment Update and Study Results (00:00:08)

3. Effectiveness of Paxlovid for COVID-19 (00:12:46)

304 episodi

Artwork
iconCondividi
 
Manage episode 418005992 series 2931422
Contenuto fornito da CEimpact. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da CEimpact o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Join us as we explore new trial data examing Paxlovid's effectiveness in high-risk, vaccinated patients.
The GameChanger
Significantly high risk patients are still at risk from active Covid-19 infection. A new trial looks at Paxlovid use in high-risk, vaccincated patients.
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
New England Journal of Medicine Article
Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss EPIC SR study findings.
2. Describe benefits of Paxlovid for specific patient groups based on trial data.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-172-H01-P
Initial release date: 05/13/2024
Expiration date: 05/13/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

  continue reading

Capitoli

1. Paxlovid in COVID-19 Vaccinated patients (00:00:00)

2. COVID Treatment Update and Study Results (00:00:08)

3. Effectiveness of Paxlovid for COVID-19 (00:12:46)

304 episodi

Alle afleveringen

×
 
Loading …

Benvenuto su Player FM!

Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.

 

Guida rapida